Saranas has developed a technology that allows for the early detection of bleeding complications associated with vascular access procedures.
The system is comprised of a standard cardiac sheath that is surrounded by an array of electrodes. These electrodes measure the difference in electrical resistance across the vessel. When a vessel is ruptured, blood begins to accumulate outside of the vessel, causing a change in the electrical resistance.
The Saranas system allows for the rapid detection of internal bleeding complications and enables physicians to mitigate the downstream consequences by addressing the complication immediately using accepted, straightforward adjustments to the flow of the procedure.
Each year, over 20 million patients in the US require access to a blood vessel for surgical and non-surgical procedures known as vascular access procedures.
Approximately 1 million of these patients experience a severe bleeding complication, resulting in significant additional healthcare expenditures and placing the patient at an increased risk of death.
Currently there is no cost effective technology that can alert clinicians early enough to prevent bleeding complications from becoming a life-threatening and expensive emergency. With healthcare costs under increasing public scrutiny, hospitals are unlikely to receive additional reimbursement for these procedures.
Starting 2015, 25% of all hospitals with the highest incidence of medical complications will lose 1% of their entire Medicare reimbursement (an estimated $1.7 billion nationwide). Total direct and indirect costs of internal bleeding complications are estimated to be $8.4 billion.
Early detection will avoid most downstream costs listed
24% Overall Complication Rate
*This product currently is not for sale in the US, EU or Canada. However, we are working with regulatory agencies to make the Saranas system available around the world!